Newly Created Positions to Drive Growth in Pharmaceutical and Nutritional Product Sectors and Enhance Global Access to Henry Schein Products
MELVILLE, N.Y. – October 19, 2015 – Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, today announced that it has appointed Gilles Guillemette to the position of Vice President and General Manager, Global Animal Health Pharmaceutical and Nutritional Products, and Robert DiMarzo to the position of Vice President, Commercial Development and Product Category Management – Global Animal Health Group.
The newly created positions demonstrate the Company’s commitment to driving growth in the critical areas of pharmaceutical and nutritional products, and to making Henry Schein products from highly respected brands such as scil animal care, Vet Instrumentation and Jorgen Kruuse A/S more available to its customers globally.
Henry Schein's animal health business has operations or affiliates in 23 countries, including the United States, Australia, New Zealand, Canada, China, Malaysia and 17 countries in Europe. In 2014, Henry Schein's Global Animal Health business had sales of approximately $2.9 billion.
Mr. Guillemette brings more than 25 years of business management experience within the animal health industry in Europe and North America. He most recently served as Vice President, Business Planning and Strategy for Bayer Health Care – Animal Health. Prior to that, he worked for Johnson & Johnson – Noramco Animal Health as Area Director – North America. After practicing small animal veterinary medicine in Nice, France, Mr. Guillemette began his career in industry at Colgate-Palmolive in its pet food division (Hill’s Pet Nutrition) in France, the U.K. and the U.S.
“Gilles’ experience in the animal health industry, both as a veterinarian and as a business leader, makes him the ideal person to build on our pharmaceutical and nutritional product strategy and grow Henry Schein’s presence in these important sectors,” said Peter McCarthy, President, Henry Schein Global Animal Health Group. “We look forward to Gilles working closely with our current supplier partners and forging new pharmaceutical and diet partnerships. Henry Schein Animal Health is committed to delivering more high-quality products and solutions to our veterinary customers.”
Mr. Guillemette earned his degree in veterinary medicine from the Nantes Veterinary School in France, where he also studied food processing engineering. He will be based in Melville, New York.
Mr. DiMarzo joins Henry Schein with more than 25 years of business management experience, serving most recently as a consultant to business and financial entities on global strategies, business development and advancing the growth of animal health and human biotechnology industries. Prior to that, he was the Executive Chairman for Ivesco Holdings, an animal health distribution company. Before entering business, he served as a United States Naval Officer and also spent time in the U.S. Peace Corps.
“Robert’s unique leadership background and industry expertise will serve him well as he works to ensure that our animal health customers around the world have access to products offered by the Henry Schein companies,” McCarthy said. “Each of the scil, Veterinary Instrumentation and Kruuse brands, as well as Henry Schein branded products, drive unique value propositions within veterinary clinics. Robert will lead our efforts to provide veterinarians around the world with the best possible products, services and solutions, which has long been a hallmark of Henry Schein.”
Mr. DiMarzo earned an MBA in General Management, Marketing and Finance from Harvard Graduate School of Business Administration and a Bachelor of Science degree in Aquatic Biology from Brown University. He will be based in Melville, New York.
About Henry Schein Animal Health, U.S.
Henry Schein Animal Health, based in Dublin, Ohio, is the leading companion animal health distribution company in the United States, and the U.S. animal health business of Henry Schein, Inc. (NASDAQ: HSIC). The Company employs approximately 900 team members, including 300 field sales representatives and 200 telesales and customer support representatives. With 12 strategically located, state-of-the-art distribution facilities and 10 inside sales centers, the Company maintains a greater than a 99 percent order-fill ratio, accomplishing its mission of providing the right product at the right place and at the right time.
Henry Schein Animal Health partners with more than 500 global suppliers to bring veterinarians the broadest selection of health care products to companion animal, equine and large animal practices, including dentistry, diagnostics, diets, equipment and supplies, nutraceuticals, oncology, orthopedics, parasiticides and pharmaceuticals. In addition, the Company helps veterinarians grow their practice with its strategic Business Solutions, including AVImark® and ImproMed® Practice Management Software, CHOICE Diagnostics™, Henry Schein® Axis-Q™, Henry Schein® Financial Services, Henry Schein® ProRepair®, Henry Schein® Rapport™, MyVetDirect.com® Home Delivery, Practice Partners (HRVetResource, Intelligent Inventory®, Leadership Intelligence, Employee Resource Manual and OSHA Compliance), Privacy Edge Identity Theft Protection, Professional Development Program, SmartPak™ ColicCare™, VetPressOnline Client Communications and Veterinary Instrumentation™. For more information, visit www.henryscheinvet.com.
About Henry Schein, Inc.
Henry Schein, Inc. (NASDAQ:HSIC) is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners. The Company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. A Fortune 500® Company and a member of the S&P 500® and the NASDAQ 100® indexes, Henry Schein employs more than 18,000 Team Schein Members and serves more than one million customers.
The Company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 100,000 branded products and Henry Schein private-brand products in stock, as well as more than 150,000 additional products available as special-order items. The Company also offers its customers exclusive, innovative technology solutions, including practice management software and e-commerce solutions, as well as a broad range of financial services.
Headquartered in Melville, N.Y., Henry Schein has operations or affiliates in 33 countries. The Company's sales reached a record $10.4 billion in 2014, and have grown at a compound annual rate of approximately 16 percent since Henry Schein became a public company in 1995. For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein and @HenrySchein on Twitter.
CONTACT: Susan Vassallo
Vice President, Corporate Communications